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Objectives. This report describes tnroeophaged echamMio-
graphic guidance of tenmalheter closure of venricular sepal
defects and Its value as an adjust to loereucepy and anglography
In this procedure.
Background. Experience with traseathete closure of ve tric-
uhr sepal defects has Identified a diverse group of patients i
whom it may be the procedure of choice. Although facilitating
other intervathmd procedures, such s tramcathete closure of
airial septa) defects, the value of tramaophageal ahoardio-
graphic guidance for tremcdheler ventricular taped defect clo-
sure has not ben documented.
Me". Al patients who underwent ventricular sepal defect
closure
with Mmeaphapal echoardlographk guidance before
November 1992 were Inch". Aeglogrrummid echoariipams
were reviewed to evaluate device petition ad Militia Is vain these
during placement and to means resided low after device hoplimta-
dan. The ability of traseophaged echatmar&VIsphy to
moss; dome
variables was compared with Mlwaapy tad anglography .
Results, Trantsophageal eMardlographle guidance war
Transcatheter device closure may be the procedure of choice
for certain congenital, postoperative and acquired ventricu .
lar septa) defects. Proper positioning of closure devices
requires precise definition of septa] and valvar anatomy,
which may be poorly defined by sogiography alone . Echo-
cardiography is capable of imaging details of intracardiac
anatomy as well as closure devices
. However, conventional
surface echocardiography is awkward during device place-
ment because it interferes with fluoroscopy and catheter
manipulation, and the images are often of poor quality,
especially in large patients and in those who have undergone
previous surgical intervention .
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used i 31 othe 83 is tnisdom involving tnnscalheter ven ie-
dr sepal detect dome performed between February 1990 and
November 1992 . Under trusoptageal eehoardiopaphic gdd-
roe, 45 device were hapsded : 23 in muscular ventricuhr eptal
defects, 17 i rrshddud peutoperattve patch margin defects tied 5 in
other veatrlc d sepeo defcts. Tsmmpbagd a6ocardiapaphic
guidnce enhanced msewmml of device position ad permissibly to
valvestraelarw and mvkedy Improvedawenmedofresidmil bw,
Aeeaanem of reodW lag with hmmaphaged echowmapnphy
eY
milmslM the seed for maltiple aIII prr Is same pedants.
Caehiig trameuophsgd a hamdkpapby with luoretropy ad
aepapapby padded the most hlirmdan .
Combination
. Trannsephagat ecboaratopapby fadlitates
tramnstlekr dome of ventricular septa] deftss by laprovig
ausmwN of device ptehlan aid eftotheaen of dosage . It In
Indicated who device placement s pcdy i be 4NNIcuM or may
Interfere with vain shsdares or when onillp a itervedlanal
procedures are adldpeted,
(J Am CogCardsl 19Ni23:1660-5)
Several investigators have reported the use of trensesoph-
ageal echocardiography during interventional catheterza-
tion procedures (1-7). Trasesophsged echocardiography
does not interfere with execution of the procedure and
generally provides superior image quality. In this report, we
describe the use of trasesophageal echocardiographic guid-
ance of transcatheter device occlusion of ventricular septa)
defects. Possible indications for the use of tansesophageal
echocardiography during the procedure, the contributions of
trasesophageal echocardiography to correct device posi-
tioning and assessment of results are discussed .
Methods
The medical records, angiograms and echocardiograms of
all patients who underwent trans:atheter ventricular septal
defect closure between February I, 1990 and November 1,
1992 and who had a transesophageal echocardiogram during
the procedure were reviewed. Patients were identified by a
search of the computerized data bases for echocardiography
and closure devices. Before February, 1990, trasesophage-
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al echocardiography was not used during transcatheter Ven-
tricular septa) defect closure .
Informed consent. The Bard Clamshell Septa) Occluder
used for ventricular septa) defect closure is investigational,
and its use is currently restricted to centers designated by
the Food and Drug Administration . The device placement
protocol has been approved by the Food and Drug Admin-
istration and by the Committee on Clinical Investigation at
Children's Hospital
. Informed consent was obtained before
a( device
placements.
Echocardiographic examination . All patients who were
candidates fur tt
-anscatheter ventricular septal defect closure
underwent conventional surface echocardiographic exami-
nation before catheterization
. Transesophageal echocardi-
ography was used during ventricular septal defect closure
in patients who were in one or more of several higher risk
Categories : I) multiple ventricular septal defects requir-
ing device closure ; 2) anticipation of multiple additional
interventional procedures and angiograms during the same
catheterization (high contrast load) ; 3) complex septal
anatomy (such as malalignment of the apical septum) : and
4) ventricular septal defect in close proximity to valve
structures .
Transesophageal echocardiography was performed by
one of four faculty echocardiographers, using a Hewlett-
Packard Sonos 1000 or 1500 or an Acuson 128 phased- ay
imaging system equipped with pulsed, continuous wav
y
nd
color Doppler and a single-plane or biplane transesophageal
echocardiographic transducer
. A pediatric transducer was
used in patients weighing < 10 to 12 kg
. All patients under-
went general anesthesia and intubation before transesopha-
geal echocardiography, to prevent patient movement during
ventricular septa) defect device deployment
.
Methodology for transesophageal echocardiugraphic
guidance of transcatheter ventricular septal defect closure
has been described elsewhere (1) . Ventricular septal defect
anatomy, size, relation of multiple defects, if present . and
proximity to valves and other cardiac structures were deter-
mined before device placement
. Occluder arm position was
monitored during device delivery and after release, and
effectiveness of closure was evaluated using Doppler color
flow mapping.
Cardiac catheterization and ventricular septal defect
closure. Baseline hemodynamic variables were measured
before ventricular septal defect closure . Candidacy for trans-
catheter closure and the details of the procedure have been
described elsewhere (8,9) . Devices used for ventricular
septal defect occlusion included the Bard Clamshell Septal
Umbrella (17, 23, 28, 33 or 40 mm in diameter) and the Bard
PDA Umbrella (12 or 17 mm in diameter) . Device position
was assessed by fluoroscopy throughout the procedure and
afterward by angiography, when possible. The techniques
forother interventional procedures performed in some of the
patients have been described elsewhere (10-12) .
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Results
Patient characteristics. Between February 1990 and No-
vember 1992, a total of 83 catheterizations involving trans-
catheter ventricular septal defect closure were performed .
Thirty-one of these catheterizations (37%) were done using
transesophageal echocaroiographic guidance
; the clinical
characteristics of 29 patients undergoing these 31 catheter-
izations are described in Table I (median age 7 .2 years,
range 12 months to 80 years
; median weight 19.5 kg, range
6.3 to 75) .
Ventricular septa) defect was the primary cardiac diagno-
sis in 7 of 29 patients. The other 22 patients included 9 with
double-outlet right ventricle or transposition of the great
arteries with ventricular septa) defect status post Rastelli
repair (8) or arterial switch and ventricular septa) defect
closure (1)f 5 with repaired tetralogy of Fallot or tetralogy of
Fallot with pulmonary atresia ; 5 with an unrepuired
conotruncal malformation with multiple ventricular septa)
defects : I with double-outlet right ventricle with inverted
atria status post Senning and Rastelli ; and 2 with a postin-
ferction ventricular septa) defect .
These 29 patients underwent placement of 45 ventricular
septa) defect devices (43 clamshells, 2 patent ductus arte-
riosus umbrellas) in 23 muscular ventricular septal defects,
17 patch mai :in defects, 2 left ventricular to right atria]
shunts, 2 postinfarction defects and'] fenestration in a
ventricular septa) defect patch-
More than one inlerventional procedure was performed
during 19 (62%) of the 31 cardiac catheterizations !Table 2) .
Additional procedures included device closure of an atria'
septal defect or of one or more additional ventricular Sept,
defects, balloon dilation of pulmonary arteries or of the right
or left ventricular outflow met, stent placement and coil
embolization of aortopulmonary collateral vessels .
Fluoroscopic and angiographic evaluation. Device posi-
tion . After device release, the relation between the device
arms and the ventricular septum could be accurately deter-
mined by fluoroscopy and angiography in 35 of 45 devices,
Of these . 32 devices appeared to be correctly positioned,
whereas in the other 3 one or two arms appeared to be on the
wrong side of the septum . The relation of the device arms to
the septum could not be determined with certainty in the
remaining !0 devices .
Relation to valves
.
Device arms were thought to be
within 5 mm of aortic leaflets in seven devices and tricuspid
valve apparatus in five. The relation of device arms to valve
structures could not be determined by fluoroscopy and
angiography in four patients
.
Residual flow .
Angiography, performed after release of
37 devices, was helpful in assessing ventricular septal defect
closure in only 11 (30%), with residual flow graded as trivial
in 4 . small in 3 and moderate in 4 . Angiography was not
performed after placement of seven devices because of
contrast load limitations and after another because of device
embolization .
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Table 1 . Patients Undergoing Transcatheter Ventricular Septa) Defect Closure Under Trausesophageal Echocardiographic Guidance
Ao-PA-oonopulmonury ;BT-Blalak"Taussig ;DOLV=doubkro llelleftvemsick:DORV=doubkoutktsightvemrick;F=femak
;11
.D.D)=astial
thus inversus with Warped ventricles and transposition of the grew ; arteries feGAl: LV = kit vemsick ; M = male; PA - pulmonary artery; PS = puhmonuy
stenosis : PI = patient ; RA = right atrium; RVOT = right sentricularoutllow Inci ; RV-PA = right ventricle to pulmonary artery ; S/PIN - status post myocardial
infarction
: TOF = Ielrslugy of Fallos ; YSD = ventricular, seplal defect .
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In summary, fluoroscopy and angiography were inade-
quate for assessment of device position in 22% and for
proximity to valve tissue in W/o of the ventricular septa)
defect devices placed. The amount of residual flow could not
be assessed in
70% of the devices evaluated by angiography .
Transesophageal echocardiographic evaluation
. Device
position. The relation of device arms to the ventricular
septum was demonstrated by transesophageal echocardiog-
raphy in 40 of
the 45 devices, although in 2 cases one or two
arms were not well imaged. Because of
extreme anterior
location or acoustic shadowing by patch material, five de-
vices were difficult to image .
Relation to valves . Of the 45 devices, 12
were considered
close to valve tissue (6 aortic, 6 tricuspid), including 2 cases
where the device relation to valve structures could not be
assessed by fluoroscopy or angiography
. The remaining
devices, including those indistinctly imaged, were thought to
be distant from the valves . ]'we devices were considered by
angiography to be close to valve structures but were seen as
remote by transesophageal echocardiography ; review of
angiograms and echocardiograms in these two cases re-
vealed that in one the distance to the aortic valve was
difficult to determine with certainty
by transesophageal
echocardiography (and was close by angiography) ; in the
other, review of the angiogram concurred with transesoph-
ageal echocardiography that the device was not within 5 mm
of the aortic valve.
Residual flow, Residual shunting through the ventricular
septal defect as assessed by color flow mapping after device
placement was absent in five cases, trivial in six, small in
eight, moderate in two and large in three . In I I other defects
the amount of flow was significantly reduced but could not
Pt Nn./
Gender Age (yr)
Diagnosis
Previous Surgery VSD(sl Closed
I/M 9.4 TOF, absent left pulmonary artery Repair. fnestated VSD patch Patch fenestration
2JM 15.5 DORY. pulmonary anesia Rasteln Anterior muscular. patch matron
3/M 18.3 DORY. TGA . pulmonary drone Rasteni Patch margin, LV to RA no.
4fM 7 TGA. VSD . pulmonary stenosis Raslotli patch margin . LV to RA shunt
51M 44 TOP Repair Patch margin
Nht 3.1 DORY, coarmtion Arterial switch, VSD, coarcmlwn,
RVOT patch
Patch margin
7/F 5
.3 Pulmonary alresia . muscular VSD RV-PA conduit Muscular
8/F 7
.2 DOLV. multiple VSDs. pulmonary
stenosls
Right modified BT shunt Muscular
9/M 18.8 11. D, DI DORV, VSD Seaming, Rastelli Patch margin
INM 3.7 TGA-multipicVSDs PA band, BT shunt Muscular
ll/M
1Z/F
5
I
TOF
Mitmlstenosis,multiple VSDs
Repair
None
patch margin
Muscular
131M 2.6 Multiple VSD5 PA band Muscular
14/M 13 .5 Muscular VSD VSD patch Patch margin
INM 25 TGA, VSD . PS Rutelli Patch margin
INN 75 SIP MI Now Postinfarttion
17/F 80 SIP MI None Postialarction
18/F 9.8 TOP, pulmonary atresia VSD closure, R`JP.S condo/c Patch margin
19/F 7.3 WRY, satmodic stenosis Rutot i
. modified Stamel
Patch margin, muscular
2a/F 1.3 Membmnous, multiple muscular VSDs,
mitsat 51enons
Membranous YSD patch. PA band Muscular
21/M 6 .3 Multiple VSDs PA band Muscular
22/F 3 .3 Multiple VSOs SOD suture closure Muscular
231& 23 DORY, PS VSD. PS resection Patch ourgin
24/F 6 .3 TOP Repair Patch margin
25/F 6 .5 TGA, pulmonary alresu, multiple VSDs Multiple Ac-PA shunts, pulmonary
-try platy
Muscular
20/F 14 .1
DORY, PS
. deslrocardia
VSD patch. RV-PA conduit Patch margin . muscular
27/F 1 .5 Membranous. multiple muscular VSDs, PS Membranous VSD patch,
pulmonary
vat"
excision
Muscular
28/F 9 .9 DORV RaueR Patch margin
29/F
5 .9
DORY, muhipk VSDs PA Band Muscular
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Table 2 . Patients Undergoing Multiple Interventions During
Catheterization
ADD = atrial septa) defect ; collate. = aonovulmonary collateral vessels ;
emboliz . = embolimtion ; LVOT = ten venrncutzr outflow tractC other
abbreviations as in Table 1 .
be graded accurately. The amount of residual flu, after
device placement could not be determined by transesophu-
geal echocardiography in the remaining nine cases.
In summary, Iransesophageal echocardiography was in-
adequate for assessment of device arm position in 11% and
for residual flow in 20% of devices placed. Proximity to
valve tissue could be
assessed in 98% of devices .
-Additional information obtained by transesophageal
echocardiography . Previously unrecognized cardiac abnor-
malities were discovered in several patients . Large residual
interatrial communications were found in two patients who
had undergone reparative surgery (one with juxtaposition of
the atria) appendages. one with a Senning procedure far
inverted atria). These defects had not been detected by
routine hemodynamic evaluation before transesophageai
echocardiography . In five other postoperative patients (all
>5 years old), a patent foramen ovate or small atria) septal
defect with detectable flow was identified . Malalignment of
the muscular septum apical to the ventricular septal defect
was diagnosed in three patients
. Two large atria] thrombi
were detected in a patient with a postinfarction ventricular
septal defect.
Resource utilization. The average duration of transesoph-
ageal echocardiographic imaging during transcaiheter ven-
tricular septal defect closure in these 31 catheterizations was
2 .15 h (range 0 .55 to 5 .23). No morbidity related to trans-
esophageal echocardiography was observed .
Combined assessment by catheterization and transesopha-
gealechocardlography. Of the five devices poorly imaged by
transesophageal echocardiography, three were well imaged
VAN DER VELDE ET AL.
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CATH TEE COMBINED
Imaging Modality
Fid re 1
. Comparison of fluoroscopy and angiogmphy (CATH),
tetnsesophageal echocardiography , (TEE) and the combination of
both imaging modalities (COMBINED) in the assessment of device
arm
position (open bars), proximity of the ventricular septa] defect
and device to valve structures (botched bars) and location and
quantitation of residua] flow (solid bars) . The percent of devices that
could be assessed with certainty by each method for each of the
three vatiahles is displayed .
by fluoroscopy and atgiography. but two were difficult to
localize using either modality . In the 26 device closures where
angiographic assessment of residual flow was inconclusive, the
amount of residual flow could be evaluated by tronsesophageal
echocardiography in 20 (77%), The combination of techniques
resulted in improved ability to assess device position, proxim-
ity to valves and residual flow (Fig . I).
Discussion
Use of transesophageal echocardiography to guide sev-
eral types of in!erventional procedures has been previously
described, including mitral valvuloplasty (2,3), atrial septal
defect device placement (4), balloon atrial septostomy (5),
endomyocardinl biopsy in infants (6) and radiofrequency
ablation of bypass tracts (7). We have previously described
our early experience with transesophageal echocardio-
graphic guidance of transcatheterclosure of several intracar-
diac defects (I) .
Device position. During transcatheter closure of ventric-
ular septal defects, deployment of device arms is guided
radiographically using landmarks, such as sternal wires and
ribs, because septal and valve structures cannot be visual-
ized fluoroseopically unless extensively calcified (Fig
. 2).
After delivery of the distal set of arms, tension on the device
causes the arms to move in predictable directions if they are
properly positioned. However, device arms caught on other
cardiac structures (such as valve tissue) may mimic properly
positioned arms. In addition, manipulation of the device to
assess position can cause arm dislodgment . Interference
with valve structures may not be apparent until the device is
released, and angiography performed .
R No.
No. of VSD Devices Other Interventions
1 I PA dilations
7 3 (including LV.RA shunt) PA dilations, steal
2 (including LV-RA shunt)
7 ASDdotice
1
ASO device
I DOauon of RV-PA conduit
1 Dilation . stem conduit
19
LVOT dilation,
teat
20
22
24
Coil emboliz, of N collars .
25
27
2a
29
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Figure 2 . Fluoroscopic image (long-axial oblique projection) of the
ventricular septum with two clamshell devices in place afterdeploy-
meet. Three catheters are present (retrograde in left ventricle, inferior
versa cava to pulmonary artery and inferior versa cava across atria)
septum to left ventricle)
. The position of individual device amts with
respect to the septum and valve structures is difficult to determine .
Transesophageal echocardiography during device deploy-
ment allows continuous visualization of device arms and
their proximity to the septum and other cardiac structures in
the great majority of patients (Fig
. I and 3). Arms that are
positioned improperly or that interfere with valve function
can be identified before the proximal portion of the device is
deployed, while retraction and redelivery are still possible
.
Incorrect arm position appears less likely if tmnsesophageal
echocardiographic guidance is used,
Figure 3 .
Four-chamber transesophageal echocardiogaphic image
of a clamshell device properly positioned in a midmuscular ventric-
ular septal defect. LA = left atrium ; LV = left ventricle ; RA - right
atrium ; RV = right ventricle .
Although some defects (particularly very anterior ones)
can be difficult to image with tmnsesophageal echocardiog-
raphy, the combination of trausesophageal echocardiogra-
phy and fluoroscopy is likely to provide the most accurate
assessment of device position.
Residual Bow. The angiographic assessment of residual
flow is affected by the amount of contrast medium used,
proximity of the injection to the defect and the time elapsed
since device placement . Transesophageal echocardiography
may provide a more physiologic assessment of residual flow
and can be performed at multiple intervals after device
placement.
In 20 ventricular septa) defect devices with inconclusive
angiograms, transesophageat echocardiography provided
enough information about the amount and location of resid-
ual flow that further angiography was not necessary. Use of
trnsesophageal echocardiography in such situations re-
duces contrast load and radiation, increasing the number of
diagnostic and interventional procedures that can be per-
formed during a single catheterization. Further catheteriza-
tions, in turn, may be avoided .
At our institution, transcatheter device closure is used
increasingly for management of selected unoperated ventric-
ular septa) defects (9). Transcatheter closure of residual
postoperative defects has also proved useful as an alterna-
tive to reoperation, particularly for poor operative candi-
dates (13)
. Although experience with transcatheter closure
of postinfarction ventricular septa) defects is limited (8,14),
further experience may identify patients in whom transcath-
eter closure improves survival
.
FgureC Angiogram after placement of the device shown in Figure
3 . The location of the residual flow across the septum
(i .e., through
the same defect or
a separate defect at the same level) is difficult to
determine by algography alone .
JACC Val. 23, No. 7
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Figure 5
. Transesophageal echneardiographic image of the residual
lbw jet shown in Figure 4, demonstrating that the flow is not around
the device shown in Figures 3 and 4 but is instead through a separate
defect that is more posterior in the midmuscular septum
. vsd =
ventricular septa) defect ; other abbreviations as in Figure 3 .
Indications for tranaosopbageal echocardiography. On re-
view of
the 83 catheterizations involving ventricular septal
defect device placement performed during the study period,
transesophageal echocardiographic guidance appears to be
indicated when I) the ventricular septal defect is near
semilunar or atrioventticular valve tissue
; 2) the defect is
very large or complex, or septal anatomy is unusual (as with
malalignment of the apical portion of the septum) ;
3)
the
location or number of ventricular septal defects is still in
question after conventional echocardiographv and angiogm-
phy; or 4) the need for multiple interventional procedures
during the same catheterization is anticipated (Fig
. 4 and 5).
Other indications for ttansesophageal echocardiogmphic
guidance of
the procedure might include renal failure or
allergy to contrast material
.
Advastages of Iraaaesophageal echocardiography over con-
ventload
echocardiography.
The superior imaging capability
oftransesophageal echocardiography compared with surface
echo has been well described . Transesophageal echocar-
diography may identify previously unrecognized but impor-
tant cardiac abnormalities, as our study population revealed .
More important for transcatheter closure of cardiac defects,
however, is the ability to continuously monitor device posi-
tion and relation to valve tissue during device delivery
without interrupting or interfering with fluoroscopy or cath-
eter manipulation (1,2) .
Study limhatbns. Very anterior ventricular septa] de-
fects and some apical defects can be difficult to image by
transesophageal echocardiography . Technologic advances
may improve far-field penetration and resolution . Conven-
tional echocardiography, although it may provide superior
VAN DER VELDE ET AL .
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images
of these areas, is likely to interfere with the closure
procedure and has not been useful
. General anesthesia is
necessary to prevent patient movement during transcatheter
ventricular septal defect closure, particularly if transeseph-
ageal echocardiography is used.
Resource utilization . Transesophageat echocardiographic
guidance of transcother ventricular septal defect closure
requires a time commitment by the echocandiographer and
equipment that may be prohibitive in some situations .
Conclusions
. Transesophageal echocardiography is a
useful and frequently necessary adjunct to
fluoroscopy and
angiography for guidance of transcatheter ventricular septa]
defect closure and is especially indicated when positioning of
the device is likely to be difficult or to interfere with valve
structures or when multiple interventional procedures are
anticipated .
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